U.S. Physical Therapy’s (USPH) “Market Perform” Rating Reiterated at William Blair

William Blair reaffirmed their market perform rating on shares of U.S. Physical Therapy (NYSE:USPH) in a research note released on Thursday morning,RTT News reports.

Several other research analysts have also commented on USPH. JPMorgan Chase & Co. lifted their target price on U.S. Physical Therapy from $117.00 to $120.00 and gave the stock an “overweight” rating in a research report on Tuesday, December 3rd. Barrington Research reaffirmed an “outperform” rating and issued a $108.00 price objective on shares of U.S. Physical Therapy in a report on Thursday, November 21st. Bank of America raised shares of U.S. Physical Therapy from a “neutral” rating to a “buy” rating and increased their target price for the stock from $100.00 to $115.00 in a report on Monday, December 16th. Citizens Jmp raised shares of U.S. Physical Therapy to a “strong-buy” rating in a report on Monday, December 16th. Finally, JMP Securities started coverage on shares of U.S. Physical Therapy in a research note on Monday, December 16th. They set an “outperform” rating and a $113.00 price objective on the stock. Two investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $114.00.

U.S. Physical Therapy Trading Down 6.2 %

NYSE USPH opened at $82.25 on Thursday. The company has a market capitalization of $1.24 billion, a price-to-earnings ratio of 87.50, a price-to-earnings-growth ratio of 3.54 and a beta of 1.48. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.78 and a quick ratio of 1.78. U.S. Physical Therapy has a 12 month low of $76.18 and a 12 month high of $113.63. The company’s fifty day moving average price is $88.41 and its two-hundred day moving average price is $87.67.

U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings results on Wednesday, February 26th. The company reported $0.65 EPS for the quarter, missing the consensus estimate of $0.69 by ($0.04). The company had revenue of $180.45 million for the quarter, compared to the consensus estimate of $173.10 million. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. As a group, research analysts predict that U.S. Physical Therapy will post 2.67 earnings per share for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The company also recently declared a dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 14th will be issued a dividend of $0.45 per share. The ex-dividend date of this dividend is Friday, March 14th. U.S. Physical Therapy’s dividend payout ratio (DPR) is 187.23%.

Insider Transactions at U.S. Physical Therapy

In other U.S. Physical Therapy news, CFO Carey P. Hendrickson sold 516 shares of the business’s stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $96.25, for a total transaction of $49,665.00. Following the completion of the transaction, the chief financial officer now directly owns 20,469 shares of the company’s stock, valued at $1,970,141.25. The trade was a 2.46 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 1.70% of the company’s stock.

Institutional Investors Weigh In On U.S. Physical Therapy

Several large investors have recently made changes to their positions in the company. HighTower Advisors LLC grew its holdings in U.S. Physical Therapy by 2.5% in the 4th quarter. HighTower Advisors LLC now owns 4,833 shares of the company’s stock worth $429,000 after buying an additional 119 shares in the last quarter. CBIZ Investment Advisory Services LLC boosted its position in U.S. Physical Therapy by 59.8% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company’s stock worth $29,000 after acquiring an additional 122 shares during the period. Albert D Mason Inc. grew its stake in shares of U.S. Physical Therapy by 1.3% in the fourth quarter. Albert D Mason Inc. now owns 10,596 shares of the company’s stock worth $940,000 after purchasing an additional 139 shares in the last quarter. Harbor Capital Advisors Inc. increased its holdings in shares of U.S. Physical Therapy by 1.0% during the fourth quarter. Harbor Capital Advisors Inc. now owns 16,344 shares of the company’s stock valued at $1,450,000 after purchasing an additional 156 shares during the period. Finally, Aquatic Capital Management LLC raised its stake in shares of U.S. Physical Therapy by 18.0% during the fourth quarter. Aquatic Capital Management LLC now owns 1,298 shares of the company’s stock valued at $115,000 after purchasing an additional 198 shares in the last quarter.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.